Tumor and intratumoral pathogen cascade-targeting photothermal nanotherapeutics for boosted immunotherapy of colorectal cancer
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.01.048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Youtao Xin und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Separation Membranes and Membrane Processes & Key Laboratory of Hollow Fiber Membrane Materials and Membrane Processes (MOE) …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immunotherapy, Photothermal Therapy, Fusobacterium nucleatum. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Tianjin Municipal Science and Technology Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Clinical benefits of immunotherapy in colorectal cancer (CRC) are limited due to the low immunogenicity and immunosuppressive tumor microenvironment. Fusobacterium nucleatum (Fn) is discovered to colonize CRC tumors and dampen immunotherapy by fostering an immunosuppressive TME. Herein, a controllable "Shielding-deshielding" N-acetylgalactosamine (GalNAc)-derived photothermal nanotherapeutic is developed to mediate cascade targeting toward tumor and intratumoral Fn for enhanced photothermal-immunotherapy. This nanotherapeutic can in situ generate near infrared-II laser-activatable photothermal agent by reacting with endogenous hydrogen sulfide in CRC. The Schiff bond-tethered hyaluronic acid coating not only facilitates precise localization within CRC but shieldes GalNAc-mediated liver targeting, which can be deshielded upon a slightly acidic TME to anchor Fn by binding to its lectin Fap2. This cascade-targeting nanotherapeutic enables efficacious tumor accumulation and reinforces photothermal therapy (PTT) efficacy. Notably, PTT efficiently induces immunogenic cell death in CRC cells, leading to augmented immunogenicity and CD8+ T cell activation. Meanwhile, synchronous eradication of Fn facilitates M1 macrophage polarization, and promotes intratumoral infiltration of CD8+ T cell by reducing succinic acid level, thereby further boosting antitumor immunity against both primary and distant tumors. Overall, this study involving cascade targeting-reinforced PTT and intratumoral microorganism modulation offers new insight into effective CRC immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Separation Membranes and Membrane Processes & Key Laboratory of Hollow Fiber Membrane Materials and Membrane Processes (MOE) & Tianjin Key Laboratory of Hollow Fiber Membrane Materials and Proces…
- School of Biotechnology, Badr University in Cairo, Badr City, Cairo 11829, Egypt.
- Hebei Key Laboratory of Functional Polymers, School of Chemical Engineering and Technology, Hebei University of Technology, Tianjin 300130, China.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Xin, Y., Yu, Y., Wu, M., Su, M., Elsabahy, M., Qu, X., & Gao, H. (2025). Tumor and intratumoral pathogen cascade-targeting photothermal nanotherapeutics for boosted immunotherapy of colorectal cancer. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.01.048
Vancouver
Xin Y, Yu Y, Wu M, Su M, Elsabahy M, Qu X, et al. Tumor and intratumoral pathogen cascade-targeting photothermal nanotherapeutics for boosted immunotherapy of colorectal cancer. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.01.048
BibTeX
@article{Xin2025,
author = {Xin, Youtao and Yu, Yunjian and Wu, Mengdi and Su, Meihui and Elsabahy, Mahmoud and Qu, Xiongwei and Gao, Hui},
title = {Tumor and intratumoral pathogen cascade-targeting photothermal nanotherapeutics for boosted immunotherapy of colorectal cancer},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.01.048}
}
EUVIMED